This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovations of Steven L Gallion
Introduction
Steven L Gallion is an accomplished inventor based in Woburn, MA (US). He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of elastase inhibitors. His work has implications for treating inflammatory diseases associated with neutrophils.
Latest Patents
Gallion holds a patent for elastase inhibitors, which are compounds designed to inhibit human neutrophil elastase. These inhibitors are short, synthetic peptides that feature various nitrogen-containing heterocyclic groups. The invention is particularly useful in treating patients suffering from neutrophil-associated inflammatory diseases.
Career Highlights
Gallion's career is marked by his role at Aventis Pharmaceuticals Inc., where he has made notable advancements in pharmaceutical research. His expertise in developing therapeutic compounds has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Gallion has collaborated with esteemed colleagues, including William A Metz Jr and Joseph P Burkhart. These partnerships have fostered innovation and contributed to the success of his projects.
Conclusion
Steven L Gallion's work in developing elastase inhibitors showcases his dedication to advancing medical science. His contributions have the potential to improve treatment options for patients with inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile